Compound Detail
CHEMBL18701
RO-201724 Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL18701 |
| Name | RO-201724 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PDMUULPVBYQBBK-UHFFFAOYSA-N |
9
Targets
20
Activities
3
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
278.4
MW (Da)
2.10
ALogP
3
HBA
2
HBD
59.6
PSA (Ų)
0.75
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 17 meas. best 5.75
EC50 2 meas. best 6.92
Ki 1 meas. best 5.71
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cavia porcellus CHEMBL369 | EC50 | 6.92 | 6.92 | 120.0 | 1 |
| Homo sapiens CHEMBL372 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | Ki | 5.71 | 5.71 | 1930.0 | 1 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 5.7 | 5.2 | 2000.0 | 3 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | EC50 | 5.48 | 5.48 | 3300.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | IC50 | 5.37 | 5.37 | 4300.0 | 1 |
| Phosphodiesterase 4 CHEMBL2094267 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Phosphodiesterase; PDE3 & PDE4 CHEMBL2095153 | IC50 | 5.04 | 5.04 | 9100.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.95 | 4.54 | 11316.0 | 2 |
| Tumor necrosis factor CHEMBL1825 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 6292419 | 10.1021/jm00352a019 | Unchecked | 4 |
| 21456625 | 10.1021/jm200070e | 3',5'-cyclic-AMP phosphodiesterase 4A | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 9379444 | 10.1021/jm970089s | Cavia porcellus | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 2544722 | 10.1021/jm00127a009 | Phosphodiesterase 4 | 1 |
| 7490734 | 10.1021/jm00024a012 | Homo sapiens | 1 |
| 8568809 | 10.1021/jm940845j | Tumor necrosis factor | 1 |
| 2985781 | 10.1021/jm50001a001 | Phosphodiesterase; PDE3 & PDE4 | 1 |
| 2985781 | 10.1021/jm50001a001 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 1 |
| 2985781 | 10.1021/jm50001a001 | Phosphodiesterase 1 | 1 |
| 1992129 | 10.1021/jm00105a045 | Phosphodiesterase 4 | 1 |
| 9379444 | 10.1021/jm970089s | Phosphodiesterase 1 | 1 |
| 2544722 | 10.1021/jm00127a009 | Phosphodiesterase 1 | 1 |
| 6292419 | 10.1021/jm00352a019 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 1 |
| 33412421 | 10.1016/j.ejmech.2020.113123 | Phosphodiesterase 4 | 1 |
| 2579237 | 10.1021/jm00381a019 | Sodium channel alpha subunits; brain (Types I, II, III) | 1 |
| 9379444 | 10.1021/jm970089s | Phosphodiesterase 4 | 1 |
Data from ChEMBL 36 via Core Engine